Microbiological findings and antibiotic treatment in community-acquired pneumonia: a retrospective cohort study. [PDF]
Shanmuganathan S +3 more
europepmc +1 more source
Myasthenia gravis and community-acquired pneumonia: therapeutic challenges. [PDF]
Chen X, Ding J, Zhang J, Dai H, Yu L.
europepmc +1 more source
Endotoxemia and its association with immune and coagulopathy responses in severe community-acquired pneumonia and COVID-19. [PDF]
Blot M +12 more
europepmc +1 more source
Clinical characteristics of community acquired pneumonia due to <i>Mycoplasma pneumoniae:</i> experience from an outbreak. [PDF]
Nair AA +5 more
europepmc +1 more source
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial. [PDF]
Stylianakis E +20 more
europepmc +1 more source
Clinical outcomes in hospitalized patients with community-acquired pneumonia: A comprehensive analysis of associated factors. [PDF]
Rahme D, Nakkash Chmaisse H, Salameh P.
europepmc +1 more source
Comparison of CURB-65 and qSOFA scores in predicting outcomes in community-acquired pneumonia. [PDF]
Gaire M +9 more
europepmc +1 more source
Racial disparities in antibiotic selection for community-acquired pneumonia in hospitalized patients. [PDF]
Walker RE +5 more
europepmc +1 more source

